UK industry welcomes Budget boosts for life sciences

New R&D tax incentives for SMEs, funding for the medicines regulator and ‘hidden benefits’ delight the UK bioindustry.

Edwards Lifesciences revives Fintiv challenge

The medtech company and its fellow tech giant plaintiffs can now challenge the controversial rule.

Abbott fails to stay claims in baby formula milk dispute

“Customer suit exception” is rejected by district judge leaving the suit involving Chr. Hansen and Glycosyn ongoing.

Latest news